Brown KD - Search Results

1

Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases.

Ai L, Vo QN, Zuo C, Li L, Ling W, Suen JY, Hanna E, Brown KD, Fan CY. Ai L, et al. Among authors: brown kd. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):150-6. doi: 10.1158/1055-9965.epi-082-3. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744748

2

Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line.

Kim WJ, Vo QN, Shrivastav M, Lataxes TA, Brown KD. Kim WJ, et al. Among authors: brown kd. Oncogene. 2002 May 30;21(24):3864-71. doi: 10.1038/sj.onc.1205485. Oncogene. 2002. PMID: 12032824

3

The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms.

Bolt J, Vo QN, Kim WJ, McWhorter AJ, Thomson J, Hagensee ME, Friedlander P, Brown KD, Gilbert J. Bolt J, et al. Among authors: brown kd. Oral Oncol. 2005 Nov;41(10):1013-20. doi: 10.1016/j.oraloncology.2005.06.003. Epub 2005 Aug 31. Oral Oncol. 2005. PMID: 16139561

4

The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.

Vo QN, Kim WJ, Cvitanovic L, Boudreau DA, Ginzinger DG, Brown KD. Vo QN, et al. Among authors: brown kd. Oncogene. 2004 Dec 16;23(58):9432-7. doi: 10.1038/sj.onc.1208092. Oncogene. 2004. PMID: 15516988

5

Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression.

Ai L, Kim WJ, Kim TY, Fields CR, Massoll NA, Robertson KD, Brown KD. Ai L, et al. Among authors: brown kd. Cancer Res. 2006 Aug 15;66(16):7899-909. doi: 10.1158/0008-5472.CAN-06-0576. Cancer Res. 2006. PMID: 16912163

6

Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ light chain enhancer of activated B cells (NFκB) signaling controls basal and DNA damage-induced transglutaminase 2 expression.

Ai L, Skehan RR, Saydi J, Lin T, Brown KD. Ai L, et al. Among authors: brown kd. J Biol Chem. 2012 May 25;287(22):18330-41. doi: 10.1074/jbc.M112.339317. Epub 2012 Apr 4. J Biol Chem. 2012. PMID: 22493284 Free PMC article.

7

TRIM29 suppresses TWIST1 and invasive breast cancer behavior.

Ai L, Kim WJ, Alpay M, Tang M, Pardo CE, Hatakeyama S, May WS, Kladde MP, Heldermon CD, Siegel EM, Brown KD. Ai L, et al. Among authors: brown kd. Cancer Res. 2014 Sep 1;74(17):4875-87. doi: 10.1158/0008-5472.CAN-13-3579. Epub 2014 Jun 20. Cancer Res. 2014. PMID: 24950909 Free PMC article.

8

Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.

Qiu J, Ai L, Ramachandran C, Yao B, Gopalakrishnan S, Fields CR, Delmas AL, Dyer LM, Melnick SJ, Yachnis AT, Schwartz PH, Fine HA, Brown KD, Robertson KD. Qiu J, et al. Among authors: brown kd. Lab Invest. 2008 Sep;88(9):910-25. doi: 10.1038/labinvest.2008.66. Epub 2008 Jul 7. Lab Invest. 2008. PMID: 18607344 Free PMC article.

9

The transglutaminase 2 gene is aberrantly hypermethylated in glioma.

Dyer LM, Schooler KP, Ai L, Klop C, Qiu J, Robertson KD, Brown KD. Dyer LM, et al. Among authors: brown kd. J Neurooncol. 2011 Feb;101(3):429-40. doi: 10.1007/s11060-010-0277-7. Epub 2010 Jul 3. J Neurooncol. 2011. PMID: 20596752 Free PMC article.

10

Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.

Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD. Ai L, et al. Among authors: brown kd. Carcinogenesis. 2006 Jul;27(7):1341-8. doi: 10.1093/carcin/bgi379. Epub 2006 Feb 25. Carcinogenesis. 2006. PMID: 16501252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page